Cardio Diagnostics Holdings is trading at $1.76, up +5.39%, with healthcare-sector strength providing context.

  • No verified company-specific announcement for October 15 explains the move; the latest company-specific items found were older.
  • Reporting cites strong third-quarter results and raised guidance from UnitedHealth and Johnson & Johnson as healthcare-sector catalysts.
  • The broader market picture is mixed, and the sector rally is not a confirmed direct cause.